Exploiting a quantum technology step forward in a mature market will never be easy, certainly not in the short-term, especially in a product as perennially well-supplied as PET. This is the challenge that the US market-leader in the sector, Eastman C

摘要

The handful of processors currently beavering to meet demand for devices to apply GSK's anti-bird flu treatment Relenza, or by its scientific name Zanamivir, will have been encouraged by the recommendations this week of a high-powered committee of the Royal Society and the Academy of Medical Sciences.